Status:

COMPLETED

Effects of Interval Training Effects on Cardiac Fibrosis

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Fibrosis Myocardial

Eligibility:

All Genders

21-80 years

Phase:

NA

Brief Summary

The study aimed to highlight the effect of high-intensity interval training (HIIT) on cardiac fibrosis in cardiac patients. From 2009-2018, cardiac patients with measurements of VO2peak, b-type natriu...

Detailed Description

From January 1, 2009 to December 31, 2018, cardiac patients with stable clinical status for greater than 4 weeks have completed 36 times of HIIT. Subjects with clinical assessments (listed below) befo...

Eligibility Criteria

Inclusion

  • Heart failure patients, diagnosed according to the Framingham heart failure diagnostic criteria, with stable clinical status for greater than 4 weeks after conservative treatment or intervention were enrolled in the study.

Exclusion

  • Those who were
  • \< 20 years
  • under anti-coagulant therapy
  • unable to exercise \> 1 year owing to non-cardiovascular disease
  • pregnant or plan to be pregnant within one year
  • plan to have cardiac transplant within 6 months
  • uncorrected valvular heart disease related heart failure
  • congenital heart disease related heart failure
  • Other exercise contraindications:
  • unstable angina
  • resting systolic blood pressure\> 200 mmHg or resting diastolic blood pressure\> 110 mmHg
  • orthostatic blood pressure drop (systolic blood pressure drop \> 20 mmHg)。
  • critical aortic stenosis stenosis (peak systolic pressure gradient\> 50 mmHg and aortic valve opening \< 0.75 cm2)。
  • acute fever
  • uncontrolled uncontrolled atrial or ventricular dysrhythmias
  • uncompensated congestive heart failure
  • 3-degree AV block)
  • acute pericarditis and/or myocarditis
  • recent embolism \< 6 months
  • thrombophlebitis
  • restin ST segment displacement \> 2mm
  • patients with uncontrolled diabetes (resting serum glucose \> 300mg/dL or \> 250mg/dL with ketone body) was excluded in the study.

Key Trial Info

Start Date :

August 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2018

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT04038723

Start Date

August 1 2015

End Date

July 31 2018

Last Update

July 31 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.